Physician profile
Carrie E Wolfe
NPI 1841399227
$1,440.75
in general payments reported to CMS, 2019-2025
10 companies · $428 in 2025
The $428 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2020: $17.04 · 2021: $40.96 · 2022: $396 · 2023: $309 · 2025: $428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $737.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $737.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $568.57 | 2019-2025 | Tryptyr, Precision 1 |
| New World Medical,INC. | $257.02 | 2022-2025 | Clearpath, Via360, Streamline |
| Bausch & Lomb Americas INC. | $183.65 | 2023-2025 | Infuse |
| Sight Sciences, INC. | $147.08 | 2022 | |
| Coopervision INC. | $110.51 | 2019-2023 | Misight Contact Lens |
| Biotissue Holdings INC. | $58.43 | 2023 | |
| Oyster Point Pharma, INC. | $48.33 | 2023 | Tyrvaya |
| Harrow Eye, LLC | $36.47 | 2025 | Vevye |
| Johnson & Johnson Vision Care, INC. | $17.04 | 2020 | |
| Novartis Pharmaceuticals Corporation | $13.65 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carrie Wolfe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.